Reproxalap ophthalmic solution

reproxalap · Aldeyra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reproxalap ophthalmic solution, covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 2]

See pricing